MIMS Education

Practical Use of NOACs in Patients with NVAF

Practical Use of NOACs in Patients with NVAF

CardiologyInternal MedicineFamily MedicineGeneral Practice
A badge with ribbon in color black No CME/CPD credits | An analog clock in color black 45 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 26 Sep 2024 


About this course

The availability of non-vitamin K antagonist oral anticoagulants (NOACs) have paved the way for improved safety in anticoagulation among patients with atrial fibrillation without compromising efficacy. However, the use of NOACs varies depending on the specific drug, indication, and patient characteristics. This e-learning module reviews practical considerations in choosing and initiating use of NOACs for patients with non-valvular atrial fibrillation, discusses considerations in special populations, and management options for instances of bleeding complications. A review of current real-world experience on NOACs is included to shed light on the clinical experience of various institutions using these medications.

Learning outcomes

Upon completion of the educational activity, participants should be able to:
  • Identify the practical considerations in initiating and choosing NOACs for non-valvular atrial fibrillation (NVAF)
  • Review the management options in patients on NOACs with bleeding complications
  • Understand the use of NOACs in special populations

Topics covered

  • NOACs: indications and dosing
  • Choosing NOACs: absorption, metabolism, and drug-drug Interaction
  • Management of bleeding under NOAC therapy
  • NOACs in special populations
  • Real-world data on NOACs
Keywords: NOACs, atrial fibrillation, special populations, bleeding complications

Something went wrong.